These are medications for which bloating appears among the most-reported events in FDA adverse event reports. A report does not mean the drug caused the event. Report counts largely reflect how widely a drug is used and how often events are reported; they cannot be used to compare or rank drugs by risk. This list shows drugs where this event is among their top reported reactions, not every drug ever associated with it. This information is not medical advice. Do not stop or change a medication based on this data; discuss any concerns with your healthcare provider. Data from the FDA Adverse Event Monitoring System (AEMS), formerly FAERS, via OpenFDA.

A swelling or bloating of the belly, which can feel tight, full, or visibly enlarged. It can result from gas, fluid, or other factors, and can be brief or persistent. In adverse event reports, it covers reported bloating or visible abdominal swelling. Full definition in the glossary →

Medications with FDA adverse event reports of bloating, by report count
DrugReports of this event% of drug's total reports
Miralax2,1272.4%
Mirena1,7151.3%
Entyvio1,5891.9%
Ozempic1,4822.4%
Byetta1,3112.5%
Entyvio Pen1,2872.2%
Trulicity1,1521.3%
Linzess1,1344.4%
Flagyl1,0451.7%
Plan B One-step9872.6%
Alli9714.2%
Mounjaro9191.1%
Mounjaro Kwikpen9191.1%
Imodium A-d7531.7%
Imodium Multi-symptom Relief6001.9%
Victoza5841.4%
Zepbound5671.0%
Zepbound Kwikpen5671.0%
Yaz4741.5%
Extraneal4641.5%
Yasmin3481.4%
Heparin Sodium And Dextrose2722.1%
Heparin Sodium2712.1%
Tamiflu2431.4%
Cordarone2412.2%
Veltassa1471.1%
Harvoni1380.7%
Rybelsus1121.7%

← All adverse event pages